CVS Health Reports First Quarter Results And Confirms 2018 Full Year Outlook
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/20/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
CVS Health (CVS) PT Raised to $91 at RBC Capital; Technical Issues Weighing on Shares
May 3, 2018 8:39 AM EDTRBC Capital raised its price target on CVS Health (NYSE: CVS) to $91.00 (from $89.00) while maintaining a Outperform rating.
Analyst George Hill commented, "CVS reported Q1 results that beat our estimates and consensus, driven by stronger- than-expected results in the Pharmacy/LTC... More
CVS Health (CVS) Tops Q1 EPS by 6c, Q2 EPS Guidance Tops Views
May 2, 2018 6:58 AM EDTCVS Health (NYSE: CVS) reported Q1 EPS of $1.48, $0.06 better than the analyst estimate of $1.42. Revenue for the quarter came in at $45.7 billion versus the consensus estimate of $45.79 billion.
GUIDANCE:
CVS Health sees FY2018 EPS of $6.87-$7.08, versus the... More
